Aprepitant as Salvage Therapy in Patients with Chemotherapy-Induced Nausea and Emesis Refractory to Prophylaxis with 5-HT₃ Antagonists and Dexamethasone

By  

Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. : 557-561

Karger

Access to resources Recommend Favorite

Comparison of the efficacy and safety of combinations of metopimazine or ondansetron with methylprednisolone in the prevention of delayed emesis in patients receiving chemotherapy

By Bloch J.   Rixe O.   Meric J. B.   Delgado A.   Khayat D.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1763-1771

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT₃ receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States

By Schwartzberg Lee   Morrow Gary   Balu Sanjeev   Craver Chris   Gayle Julie   Cox David  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1613-1622

Informa Healthcare

Access to resources Recommend Favorite

Combination of Transcutaneous Electrical Nerve Stimulation and Ondansetron in Preventing Cisplatin-Induced Emesis

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 54-58

Karger

Access to resources Recommend Favorite

Electroacupuncture via Chronically Implanted Electrodes: Potential Treatment for Chemotherapy‐Induced Delayed Emesis

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 6, 2015-08 ,pp. : 494-498

John Wiley & Sons Inc

Access to resources Recommend Favorite